scispace - formally typeset
T

Takuji Tanaka

Researcher at Gifu University

Publications -  503
Citations -  22398

Takuji Tanaka is an academic researcher from Gifu University. The author has contributed to research in topics: Azoxymethane & Aberrant crypt foci. The author has an hindex of 75, co-authored 490 publications receiving 20946 citations. Previous affiliations of Takuji Tanaka include Japan Advanced Institute of Science and Technology & Kyoto University.

Papers
More filters
Journal ArticleDOI

A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.

TL;DR: Results indicate that 1‐week administration of 2% DSS after initiation with a low dose of AOM exerts a powerful tumor‐promoting activity in Colon carcinogenesis in male ICR mice, and may provide a novel mouse model for investigating colitis‐related colon carcinogenesis and for identifying xenobiotics with modifying effects.
Journal ArticleDOI

Size Control of Monodispersed Pt Nanoparticles and Their 2D Organization by Electrophoretic Deposition

TL;DR: In this article, a simple method to control the size of monodispersed Pt nanoparticles with the use of an alcohol reduction is described. But this method is not suitable for nanoparticles of arbitrary diameter.
Journal ArticleDOI

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

TL;DR: Treatment with polyprenoic acid significantly reduced the incidence of recurrent or new hepatomas in patients with hepatocellular carcinoma and prevents second primary hepatomas after surgical resection of the original tumor or the percutaneous injection of ethanol.
Journal ArticleDOI

Cancer Chemoprevention by Carotenoids

TL;DR: Cancer prevention using carotenoids is reviewed and the possible mechanisms of action are described.
Journal ArticleDOI

Aldehyde dehydrogenase 1A1 in stem cells and cancer

TL;DR: The functions and mechanisms of ALDH1A1, the key ALDH isozyme linked to SC populations and an important contributor to CSC function in cancers, are reviewed, and its potential in future anticancer strategies is outlined.